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Background: Although there are solid findings regarding the detrimental effect of alcohol consumption, the existing evidence on the effect of
other dietary factors on breast cancer (BC) risk is inconclusive. This study aimed to evaluate the association between dietary patterns and risk of BC
in Spanish women, stratifying by menopausal status and tumour subtype, and to compare the results with those of Alternate Healthy Index (AHEI)
and Alternate Mediterranean Diet Score (aMED).
Methods: We recruited 1017 incident BC cases and 1017 matched healthy controls of similar age (±5 years) without a history of BC. The
association between ‘a priori’ and ‘a posteriori’ developed dietary patterns and BC in general and according to menopausal status and intrinsic tumour
subtypes (ERþ /PRþ and HER2 ; HER2þ ; and ER /PR and HER2 ) was evaluated using logistic and multinomial regression models.
Results: Adherence to the Western dietary pattern was related to higher risk of BC (OR for the top vs the bottom quartile 1.46 (95% CI 1.06–2.01)),
especially in premenopausal women (OR¼ 1.75; 95% CI 1.14–2.67). In contrast, the Mediterranean pattern was related to a lower risk (OR for the
top quartile vs the bottom quartile 0.56 (95% CI 0.40–0.79)). Although the deleterious effect of the Western pattern was similarly observed in all
tumour subtypes, the protective effect of our Mediterranean pattern was stronger for triple-negative tumours (OR¼ 0.32; 95% CI 0.15–0.66 and
Pheterogeneity¼ 0.04). No association was found between adherence to the Prudent pattern and BC risk. The associations between ‘a priori’ indices
and BC risk were less marked (OR for the top vs the bottom quartile of AHEI¼ 0.69; 95% CI 0.51–0.94 and aMED¼ 0.74; 95% CI 0.46–1.18)).
Conclusions: Our results confirm the harmful effect of a Western diet on BC risk, and add new evidence on the benefits of a diet rich in fruits,
vegetables, legumes, oily fish and vegetable oils for preventing all BC subtypes, and particularly triple-negative tumours.
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Breast cancer (BC) is the most common cancer among women
worldwide and constitutes the leading cause of cancer death among
women in medium- and high-income countries (Ferlay et al, 2013).
Diet is a key modifiable risk factor for many chronic diseases
but, except for the case of alcohol consumption (WCRF/AICR,
2007), the evidence on the effect of individual dietary factors on BC
risk is inconclusive (Romieu, 2011). Some authors argue that
focussing on overall dietary patterns, instead of on individual foods
or nutrients, may better capture dietary variability in the
population’s diet while allowing the evaluation of interactions
between the dietary factors (Jacques and Tucker, 2001;
Hu, 2002; Barkoukis, 2007). However, the evidence of a possible
association between dietary patterns and BC risk remains weak
(Edefonti et al, 2009).
The primary objective of this study was to evaluate the
association between dietary patterns and BC risk in Spanish
women according to menopausal status and intrinsic tumour
subtype. The secondary objective was to compare the results of
these patterns with those of two dietary quality scores: the AHEI
(Alternate Healthy Index) and aMED (and Alternate Mediterra-
nean Diet Score) (Fung et al, 2005).
MATERIALS AND METHODS
GEICAM case–control study. Data came from a Spanish case–
control study on female BC. We recruited 1017 incident cases of
BC diagnosed in the Oncology Departments of 23 hospital
members of the Spanish Breast Cancer Research Group, GEICAM
(http://www.geicam.org/). The hospitals are located in 9 of the 17
Spanish regions and account for 78% of the Spanish population.
Each case was matched with a healthy control of similar age (±5
years), selected from cases’ in-law relatives, friends, neighbours, or
work colleagues residing in the same town.
Cases were subclassified by the following intrinsic subtypes
based on local pathology reports (Goldhirsch et al, 2011):
(1) luminal human epidermal growth factor receptor 2 (HER2)-
negative tumours (oestrogen receptor (ER)þ or progesterone
receptor (PR)þ with HER2 ), (2) HER2þ tumours (HER2þ
irrespective of ER or PR results); and (3) triple-negative tumours
(ER , PR and HER2 ). The ER, PR and HER2 positivity were
defined according to ASCO/CAP guidelines (Hammond et al,
2010; Wolff et al, 2013).
The EpiGEICAM study was approved by the Ethics Committees
of all 23 participating hospitals. All participants signed an
informed consent.
Materials. Cases and controls completed a structured question-
naire collecting information on demographic and anthropometric
characteristics, personal and family history, past physical activity
and diet. Postmenopausal status was defined as absence of
menstruation in the past 12 months.
Dietary intake in the past 5 years was estimated using a
117-item semiquantitative food frequency questionnaire (FFQ)
(Willett et al, 1985) adapted to and validated in different Spanish
adult populations (Vioque et al, 2007, 2013). The responses for
each food item were converted to mean daily intake in grams and
reduced to 26 food groups (Supplementary Appendix 1) excluding
noncaloric and alcoholic beverages. Alcohol was excluded because
it is an already established risk factor for breast cancer (WCRF/
AICR, 2007, 2010; IARC, 2012) and was included in the analysis as
a possible confounder.
Major existing dietary patterns were identified in the control
population by applying principal components analysis (PCA)
without rotation to the variance–covariance matrix. The PCA
reduces a set of intercorrelated variables (26 food groups) into a
smaller set of principal components, that is, dietary patterns. The
components are linear combinations of food groups that are
optimally weighted to successively account for decreasing propor-
tions of the total variation in the intake of the food groups. In our
case, principal components were identified among controls because
they represent the general population. The first k components that
explainX70% of the total variability in dietary intake were selected
for initial exploration. We considered food groups with component
loadings X|0.3| to strongly contribute to a dietary pattern. From
the initial k components, we retained those that were intuitively
meaningful. For each retained principal component, a score was
then calculated for cases and controls by summing the intakes of
food groups (centred to have zero means) weighted by their
component loadings.
The Alternate Healthy Eating Index (AHEI) considers the
adherence to the food guide pyramid (USDA, 1992) and the dietary
guidelines for Americans (USDA, 1995), whereas the aMED
measures the adherence to a Mediterranean diet (Fung et al, 2005).
The AHEI score is based on fixed standards of intake, whereas
aMED uses the median of consumption for each item as an
internal standard. Calculations of AHEI and aMED were based on
the criteria described by Fung et al (2005), with the only difference
being that we did not take into account the contribution of alcohol
consumption. Briefly, AHEI starts with a score of 0 and reaches a
maximum of 75 (80 when alcohol is included). Points are earned
according to the agreement with the general recommendations
regarding consumption of fruits, vegetables, nuts and soy, ratio of
white to red meat, cereal fibre, trans fats, ratio of polyunsaturated
to saturated fat and long-term multivitamin use (Supplementary
Appendix 2). After excluding alcohol, the aMED ranges from 0 to
8, with subjects starting with a score of 0 and receiving one point
for consumption above the median intake of any of the following
seven food and nutrient groups: vegetables, legumes, fruit, nuts,
whole grains, fish and ratio of monounsaturated to saturated fat.
The extra point is added for consumption of red and processed
meats below the median intake (Supplementary Appendix 3).
Associations of individual food groups with AHEI and aMED
were evaluated using Pearson’s correlation coefficients. To be
consistent with the cut point used for the PCA-derived dietary
patterns and to allow for comparison, we considered meaningful all
correlations X|0.3|.
Statistical analysis. Body mass index (BMI; 10%), physical activity
in the past year (8%), age at first delivery (5%), smoking habit
(o1%), education (o1%) and age at menarche (o1%) contained
missing values. In order to obtain unbiased estimates of the effect
of each dietary pattern using the information provided by all case–
control pairs, missing values were imputed using multiple
imputation with chained equations (Lee and Carlin, 2010; White
et al, 2011). As explained in Royston and White (2011), the
chained equations method imputes missing values in different
steps: initially, all missing values are filled at random. The first
variable with at least one missing value, say smoking, is then
regressed on the other variables including those with missing
values imputed at random in the initial step (BMI, physical activity,
age at first delivery, education and age at menarche) and another
set of potential explanatory variables that do not contain missing
(menopausal status, age, number of children, hip and waist
circumferences, bra size, calories, alcohol consumption and case–
control status). The estimation is restricted to individuals with
observed values for smoking and the missing values are replaced by
simulated draws for the posterior predictive distribution of
smoking. The next variable with missing values, say age at
menarche, is regressed on all the other variables including imputed
values of smoking and restricting estimation to individuals with
observed values for the variable to impute. Again, missing values
for age at menarche are replaced by draws from the posterior
predictive distribution. This process is repeated until a stable
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imputation is found for all values of all variables. Following this
process we created five imputed data sets that were used for
subsequent analyses. The final effect association is a weighted
average of the effects found in these five data sets.
The associations of dietary patterns and quality scores with BC
risk were evaluated using separate conditional logistic regression
models, both in quartiles and as a continuous term (per s.d.
increment). All models included the following potential confoun-
ders: total calories, alcohol consumption, BMI from self-reported
weight and height (BMI¼ kgm 2), physical activity in the past
year, smoking, education, history of breast disease other than
cancer, family history of BC, age at menarche, age at first delivery
and menopausal status. Same models were adjusted including the
interaction term between menopausal status and the corresponding
dietary pattern or score to evaluate potential effect modification of
menopausal status.
Multinomial logistic regression models were used to evaluate the
association of patterns with each of the aforementioned intrinsic
BC subtypes. These models were adjusted by age, hospital and the
same set of potential confounders described above. The Wald test
was used to compare the dose–response effect for each tumour
subtype.
Categories for quartiles of patterns/scores were collapsed with
the immediate anterior when the number of cases was o5.
For comparison purposes, the analyses for AHEI and aMED
indexes were repeated considering the original score, including
alcohol intake. Finally, the validity of the imputation was checked
by comparing the results obtained with the effects resulting from
the analyses of the data with complete information for all variables
(complete case analysis).
Analyses were performed using STATA/MP 12.0 (College
Station, TX, USA).
RESULTS
After excluding 44 case–control pairs (n¼ 88) because of
incomplete data on diet or implausible reported energy intakes
(o750 or 44500 kcal per day) in either the case or the control,
final analyses were based on 973 cases–control pairs.
Figure 1 depicts the correlation between food consumption and
‘a posteriori’ Western, Prudent and Mediterranean and ‘a priori’
AHEI and aMED scores in the control population. The PCA led to
three selected dietary patterns that respectively explained 16%, 13%
and 8% of the variation in intake of the 26 food groups. The first
component – labeled Western pattern – was characterised by high
intakes of high-fat dairy products, processed meat, refined grains,
sweets, caloric drinks and other convenience food and sauces and
by low intakes of low-fat dairy products and whole grains. The
second component – named Prudent pattern – denoted high
intakes of low-fat dairy products, vegetables, fruits, whole grains
and juices. The third component – the Mediterranean pattern –
loaded high in fish, vegetables, legumes, boiled potatoes, fruits,
olives and vegetable oil, and low in juices. All three dietary patterns
correlated positively with energy intake. The ‘a priori’ scores, AHEI
and aMED indices seemed to be similar to our Mediterranean
pattern in terms of its correlation with specific foods (fish, fruit,
vegetables and olive oil, and even legumes in the case of aMED).
Compared with controls, BC cases were more adherent to the
Western pattern, more likely to report higher energy intakes, lower
levels of physical activity and formal education and higher age at
first delivery than controls and to have history of breast problems
and a family history of BC (Table 1).
A higher Western pattern score was associated with higher odds
of BC, with the OR for the top vs the bottom quartile being 1.46
(95% CI 1.04–1.31). This association was stronger in
premenopausal women (OR¼ 1.75; 95% CI 1.14–2.67). Conver-
sely, a higher Mediterranean pattern score implied a lower BC risk,
with the OR comparing top with bottom quartiles of 0.56 (95% CI
0.40–0.79). No differences were observed between pre- and
postmenopausal women for this pattern. In both cases, the linear
dose–response trend was significant. No association was found for
the Prudent pattern. Higher scores of AHEI and aMED were also
inversely associated with BC risk, although the effect sizes were
smaller than that of the Mediterranean pattern (Table 2).
Even though coefficients for the Western pattern point to a
possible direct association with BC risk in women with HER2
tumours independently from ER/PR status, no statistically
significant differences were observed among BC subtypes (P-value
of heterogeneity¼ 0.87). Interestingly, the protective effect of the
Mediterranean pattern was stronger for triple-negative tumours
(OR for the fourth quartile¼ 0.32; 95% CI 0.15–0.66)), with a
steeper dose–response trend compared with other subtypes
(P-value of heterogeneity¼ 0.04). Results for AHEI and aMED
also showed a protective effect, especially in the case of triple-
negative BC, even if the effect size was again smaller (Table 3).
The complete case sensitivity analyses led to very similar results
(data not shown).
DISCUSSION
Summary. According to our results, a Western dietary pattern was
positively associated with BC risk. This relationship seems stronger
among premenopausal women (more likely to report this type of
diet in our sample). In contrast, our Mediterranean pattern was
associated with a reduced BC risk. Whereas a protective effect was
observed for all tumour subtypes, the size of the effect was larger
for triple-negative tumours. Compared with ‘a priori’ indices, ‘a
posteriori’ patterns identified actual dietary patterns that better
capture specific habits of the population.
Limitations and strengths. Recall bias is always a concern in
case–control studies. Some recent reviews have suggested that this
recall bias might be responsible for the effect found between a
Western pattern and BC risk in case–control studies, although the
agreement about such an effect is not that clear in cohort studies
(Brennan et al, 2010; Schwingshackl and Hoffmann, 2014).
However, most of the studies included in these reviews were
conducted in Western countries with the consequent limitations in
variability of the diet. The number of studies carried out in middle-
income countries, where the variability in food intake is wider and
food supplementation less prevalent, are still insufficient to reach
firm conclusions in this regard (Romieu, 2011). On the other hand,
cohort studies rarely update the information provided by the
participants at baseline, and this implies that, in many instances,
diet was assessed many years before breast cancer occurrence. If
the diet changes, this may entail an important degree of
misclassification and decreases the probability of observing effects
that depend more on current than in past exposure. In our case, the
temporal window considered in the FFQ included the past 5 years
before diagnosis. Furthermore, the great geographical variability
achieved by selecting recruiting centres all over the country
ensured the representation of the different diets coexisting within
Spain. The fact that some regions exhibit a higher adherence to a
Mediterranean dietary pattern increased the variability and, thus,
the power to detect an effect and to differentiate Mediterranean
from other patterns that might look similar but show no beneficial
effect in terms of BC prevention (Prudent pattern). Furthermore,
the validity and reproducibility of FFQ used in this study was
satisfactory (Vioque et al, 2007, 2013) and the strength of the
associations deemed it unlikely that our findings are a result of this
bias.
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Second, statistical power was limited in the stratified and
subgroups analyses by tumour type. On the other hand, the
matching design resulted in closely related cases and controls that
would bias the OR towards the null effect. In spite of these
limitations, we were able to detect a consistent dose–response
gradient for some dietary patterns, even in the stratified and
subgroup analyses.
Finally, a few studies have explored the association between
dietary patterns and BC risk by oestrogen and progesterone
receptor status (Baglietto et al, 2011; Woo et al, 2012) but, to our
knowledge, none has reported results by HER2 status. Our paper
fills in this important gap by exploring the link between different
diet patterns and BC risk by tumour subtype, including HER2
status.
Results in relation with other studies. Previous research on BC
risk and dietary patterns developed with PCA support the
dichotomy of Western/Unhealthy vs Prudent/Healthy pattern
(Edefonti et al, 2009). Most studies report a negative impact of a
Western/Unhealthy diet (Cui et al, 2007; Cottet et al, 2009;
De Stefani et al, 2009) and a positive effect of a Prudent/Healthy
diet (Cottet et al, 2009; De Stefani et al, 2009; Wu et al, 2009;
Demetriou et al, 2012) on BC risk. However, past studies have not
been able to differentiate between a Prudent and a Mediterranean
pattern in the same population. The former pattern captures a low-
calorie and low-fat eating profile, whereas the latter is characterised
by a high consumption of fish, legumes, vegetable oils and whole
fruits. Supporting our findings, recent BC prevention intervention
studies revealed that a reduction in fat consumption is not
sufficient for reducing BC incidence (Prentice et al, 2006; Martin
et al, 2011), whereas some prospective studies confirm the
potential primary preventive effect of a Mediterranean diet on
BC risk (Trichopoulou et al, 2010; Buckland et al, 2013). The
evidence regarding the association between BC risk and n-3/n-6
polyunsaturated fatty acids also support this Western/Mediterra-
nean dichotomy. The n-3 and n-6 PUFAs can influence breast
tumour cell growth by simultaneously competing for the same
metabolic pathway (COX and LOX pathway) to change the balance
of tissue eicosanoids, the transcription mediated by nuclear factor-
kB (NF-kB) and signal transduction mediated by the mammalian
target of rapamycin (mTOR) (Yang et al, 2014). An increase in the
intake of n-3 (present in fish, nuts and other vegetables commonly
used in the Mediterranean areas) while decreasing the intake of n-6
(present mainly in refined vegetable oils used in cookies, crackers,
sweets and fast food, typically included in the Western diet) might
reduce BC risk (Zheng et al, 2013; Yang et al, 2014). In fact, a
recent published commentary recommends the modernised
Mediterranean diet as an effective strategy to achieve an optimal
balance between n-3 and n-6 PUFAs reducing the overall cancer
risk and specifically BC risk (de Lorgeril and Salen, 2014).
Further biological explanation can be found in a recent review
that summarises the possible mechanisms explaining the effect of
Mediterranean diet on cancer risk (Grosso et al, 2013). On the one
hand, fruits and vegetables are rich in antioxidants that seem to
inhibit the growth of several tumours through stopping multiple
cancer-related biological pathways, such as carcinogen bioactiva-
tion, cell signaling, cell cycle regulation, angiogenesis and
inflammation. On the other hand, whole grains (Mediterranean
pattern) contain carbohydrates with lower glycaemic index (GI)
than refined grains (Western pattern). Products with high GI are
more insulin demanding and the insulin–IGF axis has been directly
related to cancer promotion. Olive oil counts among its potentially
health-promoting components, with tyrosol and hydroxytyrosol
that have been demonstrated to decrease glutathione (GSH), the
activation of the transcription factor NF-kB and cell death that
may be implicated in the carcinogenetic processes. Some of these
pathways seem to be particularly important in the development of
triple-negative tumours (Davis and Kaklamani, 2012; Paul et al,
2014). According to a recent review, olive oil consumption seems
to reduce the risk of several tumours, including breast cancer
(Pelucchi et al, 2011). Moreover, a negative association between
olive oil and breast density has also been reported in our country
(Garcia-Arenzana et al, 2014).
Regarding AHEI and aMED indexes, both were negatively
associated with breast cancer in our study. These two scores are
based on similar recommendations and both capture diets high in
long-chain n-3 fatty acids (Fung et al, 2005). The already-mentioned
beneficial effect of olive oil consumption may explain the lower OR
obtained with the aMED index, with oleic acid being a mono-
unsaturated fatty acid (Pelucchi et al, 2011). The original AHEI and
aMED were based on recommendations addressing cardiovascular
diseases and therefore positively scored moderate consumption of
alcohol (Fung et al, 2005). Given the evidence of a detrimental effect
of alcohol consumption on BC risk (WCRF/AICR, 2007, 2010; IARC,
2012), we decided to consider alcohol as an important confounder
and excluded this item from the score, following the example of a
Western
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Figure 1. Linear correlation between food consumption and ‘a posteriori’ Western, Prudent and Mediterranean and ‘a priori’ AHEI and aMED
scores.
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previous study that explored the association between Mediterranean
diet and BC risk (Buckland et al, 2013). As was the case in that study,
the association between the original AMED and BC was attenuated,
and the same was true for the AHEI index (see Supplementary
Appendices 4 and 5). It should be noted that alcohol consumption
was very moderate in our women, as one-third of them did not drink,
Table 1. Distribution of scores from ‘a posteriori’ and ‘a priori’ developed diet patterns and other baseline characteristics for cases and controls (the
EpiGEICAM study)
Nonmissing Co/Ca Nonmissing pairs
Controls,
n¼973
Cases,
n¼973 P-value
‘A posteriori’ extracted patterns
Western pattern, mean (s.d.) 973/973 973 0.00 (3.77) 0.62 (3.76) o0.01
Prudent pattern, mean (s.d.) 973/973 973 0.00 (3.34) 0.18 (3.30) 0.24
Mediterranean pattern, mean (s.d.) 973/973 973 0.00 (2.70)  0.16 (2.52) 0.17
‘A priori’ developed diet indices
AHEI, mean (s.d.) 973/973 973 37.16 (7.40) 36.70 (7.37) 0.17
aMED, mean (s.d.) 973/973 973 2.80 (1.06) 2.72 (1.01) 0.09
Energy intake (kcal per day), mean (s.d.) 973/973 973 1897 (628) 1990 (615) o0.01
Alcohol intake (g per day), median (IQR) 973/973 973 2 (0.04;7.10) 2.56 (0.04;8.68) 0.10
BMI, mean (s.d.) 880/871 796 25.36 (4.28) 25.56 (4.65) 0.36
Physical activity in the past year, n (%) 851/837 742 o0.01
Low 287 (30%) 338 (35%)
Moderate 368 (38%) 306 (31%)
Vigorous 246 (25%) 245 (25%)
Unknown 72 (7%) 84 (9%)
Smoking, n (%) 970/968 965 0.70
Never smoker 385 (40%) 394 (40%)
Former smoker þ6 months 260 (27%) 267 (27%)
Smoker or former smoker o6 months 325 (33%) 307 (32%)
Unknown 3 (0%) 5 (1%)
Education, n (%) 965/965 958 o0.01
Primary school or less 158 (16%) 207 (21%)
Secondary School 489 (50%) 503 (52%)
University 318 (33%) 255 (26%)
Unknown 8 (1%) 8 (1%)
History of breast problems, n (%) 973/973 973 0.05
No 796 (82%) 761 (78%)
Yes 177 (18%) 212 (22%)
Family history of BC, n (%) 973/973 973 0.01
None 782 (80%) 728 (75%)
Second degree 105 (11%) 129 (13%)
First degree 86 (9%) 116 (12%)
Age at menarche, mean (s.d.) 971/964 962 12.44 (1.52) 12.56 (1.49) 0.07
Age at first delivery, n (%) 887/967 882 0.03
o20 45 (5%) 49 (5%)
20–24 208 (21%) 229 (24%)
25–29 266 (27%) 258 (26%)
429 148 (15%) 216 (22%)
Nulliparous 220 (23%) 215 (22%)
Unknown 86 (9%) 6 (1%)
Menopausal status, n (%) 973/972 972 0.08
Pre-menopausal 513 (53%) 551 (57%)
Post-menopausal 460 (47%) 422 (43%)
Pathologic BC subtypes, n (%) 973/972 —
ERþ /PRþ and HER2 — 653 (67%)
HER2þ — 199 (21%)
ER , PR and HER2 — 119 (12%)
Unknown 2 (0%)
Abbreviations: AHEI¼Alternate Healthy Index; aMED¼Alternate Mediterranean Diet Score; BC¼breast cancer; BMI¼body mass index; Co/CA¼ controls/cases; ER¼oestrogen receptor;
HER2¼human epidermal growth factor receptor 2; IQR¼ interquartile range; PR¼progesterone receptor.
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and 75% of our drinkers had less than 1 cup per day (mean¼ 0.66
cup per day), mainly consuming wine (mean¼ 0.27 cups per day) or
beer (mean¼ 0.35 cups per day). Interestingly, alcohol intake was not
correlated with any of the ‘a posteriori’ patterns identified here
(Pearson’s correlation coefficients: Western¼ 0.020, Prudent¼
 0.020 and Mediterranean¼ 0.33, respectively), nor modified the
effect of these two patterns (data not shown).
Our results support past evidence regarding the stronger
association between the Western pattern and BC risk in pre-
menopausal than in post-menopausal women (Murtaugh et al,
2008; Agurs-Collins et al, 2009). These differences may be related
to the greater adherence to the Western pattern in younger women
as reported by Garcia-Arenzana et al (2012).
Finally, among the few studies comparing the results obtained
using ‘a priori’ and ‘a posteriori’ methods, two of them were carried
out mainly in Asian women (Wu et al, 2009; Butler et al, 2010) and
failed to identify a Mediterranean pattern using PCA, making
impossible a clear comparison. The third study, conducted in a
Mediterranean population, did obtain similar results to ours
(Demetriou et al, 2012). Regarding our differential results by
tumour subtype, our findings imply a stronger protective effect
against triple-negative tumours, supported by other studies also
suggesting a protective effect of a diet characterised by high
consumption of vegetables, fruits and/or legumes in ER /PR
tumours (Baglietto et al, 2011; Buckland et al, 2013) and HER2
tumours (Woo et al, 2012).
Table 2. Adjusted odds ratios for the association between breast cancer incidence and scores of adherence to ‘a posteriori’ and ‘a priori’ diet patterns, by
menopausal status
All women,
n¼1946
Pre-menopausal,
n¼1064
Post-menopausal,
n¼882
Co/Ca ORa (95% CI) Co/Ca ORa (95% CI) Co/Ca ORa (95% CI)
‘A posteriori’
Western pattern
Q1 244/195 1 101/76 1 143/119 1
Q2 243/224 1.20 (0.90–1.60) 120/121 1.39 (0.91–2.12) 123/103 1.08 (0.74–1.59)
Q3 242/258 1.30 (0.97–1.75) 133/153 1.54 (1.02–2.35) 109/105 1.12 (0.74–1.69)
Q4 244/296 1.46 (1.06–2.01) 159/201 1.75 (1.14–2.67) 85/95 1.22 (0.78–1.90)
P-trend 0.02 0.01 0.39
Per s.d. increase 1.17 (1.04–1.31) 1.21 (1.04–1.41) 1.12 (0.95–1.31)
Prudent pattern
Q1 244/219 1 113/118 1 131/101 1
Q2 242/252 1.19 (0.91–1.56) 143/138 0.94 (0.65–1.36) 99/114 1.60 (1.06–2.42)
Q3 244/227 1.04 (0.78–1.40) 123/135 1.01 (0.68–1.49) 121/92 1.10 (0.72–1.68)
Q4 243/275 1.09 (0.79–1.50) 134/160 0.99 (0.66–1.50) 109/115 1.22 (0.78–1.90)
P-trend 0.82 0.91 0.82
Per s.d. increase 1.00 (0.89–1.13) 0.96 (0.82–1.12) 1.04 (0.89–1.22)
Mediterranean pattern
Q1 244/246 1 134/137 1 110/109 1
Q2 243/260 0.98 (0.74–1.28) 135/151 1.00 (0.70–1.43) 108/109 0.94 (0.63–1.42)
Q3 242/264 0.88 (0.65–1.19) 120/159 1.13 (0.76–1.68) 122/105 0.67 (0.44–1.04)
Q4 244/203 0.56 (0.40–0.79) 124/104 0.58 (0.38–0.91) 120/99 0.54 (0.34–0.86)
P-trend o0.01 0.05 o0.01
Per s.d. increase 0.78 (0.69–0.89) 0.79 (0.67–0.93) 0.77 (0.66–0.91)
‘A priori’
AHEI
Q1 252/281 1 155/183 1 97/98 1
Q2 266/230 0.77 (0.59–1.00) 136/126 0.71 (0.50–1.01) 130/104 0.86 (0.57–1.29)
Q3 219/262 0.98 (0.74–1.30) 119/148 0.87 (0.61–1.25) 100/114 1.17 (0.77–1.80)
Q4 236/200 0.69 (0.51–0.94) 103/94 0.63 (0.42–0.94) 133/106 0.79 (0.51–1.23)
P-trend 0.11 0.08 0.60
Per s.d. increase 0.90 (0.81–1.00) 0.88 (0.76–1.01) 0.92 (0.79–1.08)
aMED
Q1 406/431 1 246/254 1 160/177 1
Q2 320/344 1.01 (0.81–1.25) 161/197 1.11 (0.83–1.48) 159/147 0.88 (0.62–1.24)
Q3 194/149 0.67 (0.51–0.88) 85/80 0.80 (0.54–1.17) 109/69 0.55 (0.38–0.82)
Q4 53/49 0.74 (0.46–1.18) 21/20 0.75 (0.36–1.58) 32/29 0.69 (0.38–1.26)
P-trend 0.01 0.33 0.01
Per s.d. increase 0.89 (0.80–0.98) 0.94 (0.82–1.08) 0.84 (0.72–0.97)
Abbreviations: AHEI¼Alternate Healthy Index; aMED¼Alternate Mediterranean Diet Score; CI¼ confidence interval; Co/CA¼ controls/cases; OR¼odds ratios.
aAdjusted for total calories, alcohol consumption, body mass index (BMI) from self-reported weight and height (BMI¼ kgm 2), average physical activity in the past year, smoking, education,
previous history of breast disease other than cancer, family history of breast cancer (BC), age at menarche, age at first delivery and menopausal status.
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Implications. As diet is a modifiable risk factor, the identification
of harmful and beneficial dietary habits as well as the characterisa-
tion of the population most susceptible to such habits is essential
for the design of BC prevention policies. Our results provide novel
information in these two fronts; although the potential harmful
effect of a Western diet on BC risk is widely known, the beneficial
effect of a diet rich in fruits, vegetables, legumes, oily fish and
vegetable oils over a diet low in calorie and fat intake is still
disregarded, even by the scientific community. We also identified a
higher detrimental effect of Western dietary habits in younger
women, pinpointing them as a main target for future preventive
policies. Younger women, at least in Spain, exhibit an unhealthier
lifestyle profile than their older counterparts, including a clear
departure from the traditional Mediterranean diet (Garcia-
Arenzana et al, 2012).
Finally, according to our results, adherence to a Mediterranean
diet is particularly beneficial against triple-negative tumours. As
these tumours are more aggressive, this protective effect should be
further explored.
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